Events and invitations

Introduction to Health Economics

The course aims to introduce key areas of health economics and the functioning of health systems through the lens of economic theory. It provides participants with foundational knowledge in measuring efficiency, analyzing stakeholder behavior, and applying selected analytical methods relevant to health economics.

Jakub Hlávka: Addressing the Gaps in Preparedness of Healthcare Systems for Disease-Modifying Therapies for Alzheimer’s Disease

2:30 PM – 3:30 PM

We kindly invite you to a lecture for the professional public, which will be given by Jakub Hlávka as part of his habilitation procedure. The lecture will take place on Friday, September 26, 2025, at 2:30 p.m. in lecture hall P201 at the Faculty of Economics and Administration, Masaryk University.

Disrupting Healthcare Using Deep Data and Remote Monitoring

5:00 PM

As a pioneer of Precision Medicine, Dr. Michael Snyder has invented numerous technologies that have helped shape 21st-century healthcare, including systems biology, RNA sequencing, and protein chips. He has published over 900 scientific papers and is one of the most highly cited scientists in the world. Don’t miss this unique opportunity to hear him speak about how deep data and remote monitoring are transforming the future of medicine.

Open Day 2025

9:00 AM – 4:30 PM

Are you interested in studying at a university? We invite you to the Open Day 2025, where you will learn everything you need to know about Masaryk University's study programmes!

Entrepreneurship and Innovation in Healthcare

The course aims to introduce participants to entrepreneurial principles transforming healthcare. The course explores how technologies, startups, and innovations shape healthcare delivery and how entrepreneurial approaches can improve healthcare services.

Pierre Dubois: Pharmaceutical Regulation and Incentives for Innovation in an International Perspective (MUNI Seminar Series)

4:30 PM

This lecture analyzes how pharmaceutical regulation and innovation incentives shape global R&D, access, and spillovers such as free riding, shortages, and parallel trade. It shows that international cooperation and new institutions are needed to align national policies with the global goal of sustaining pharmaceutical innovation.